Letters to the Editor: Companies that ditched DEI 'should take a hard look at the team they've joined'
To the editor: Organizations that canceled their diversity, equity and inclusion programs as the path of least resistance should take a hard look at the team they've joined ('Target learns that bowing to anti-DEI backers can be costly, a lesson for those bowing to Trump,' May 28). It's all part of the same argument throughout time. Pre-Civil War: Teach the enslaved to read and they'll be harder to keep subjugated (diversity is bad). Post-Civil War: Let them vote and they'll elect Black people (inclusion is bad). Post-civil rights: Give them equal opportunity and they'll take your job (equity is bad).
In the viewpoint President Trump sells, winning requires a loser. If DEI efforts create new winners, by that logic, they turn former winners into losers, and the status quo winners are white, male, straight and wealthy. The ultimate end of this line of thought was on display May 21 in the Oval Office, where Trump used flagrantly and instantly disprovable lies to publicly accuse the Black president of South Africa of being complicit in genocide against white people — apparently, the consequence of sacrificing apartheid in favor of allowing diversity, equity and inclusion into their democracy.
Michael Maniccia, Alhambra
..
To the editor: I pass several Targets while going from place to place doing my weekly tasks. I was not a regular Target shopper, but when they announced their commitment to DEI, I started intentionally shopping there for many of my household goods. I also continued to support them after they hired my very well-qualified African American cousin.
Speaking with her recently, she is actively seeking new employment in a DEI-supportive company and is no longer shopping at Target. I am supporting businesses such as Costco that are openly and vigorously advertising their commitment to the principles of DEI.
Sheila Troupe, Redondo Beach
This story originally appeared in Los Angeles Times.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Post
34 minutes ago
- New York Post
Hamas' cease-fire ‘counteroffer' is just a demand for Israel to give up the war
Hamas on Saturday announced it had 'responded to' the latest ceasefire proposal from US envoy Steve Witkoff, apparently seeking assurances that Israel won't simply go back to eliminating it when the 60-day pause is up. Reality check: The terrorists are only talking because they're losing, badly — losing whatever support they had from ordinary Gazans as well as militarily. Hamas' main hope is to somehow manipulate Team Trump's peace efforts into a license to survive — to somehow have the war end with it intact in Gaza, still in power and with its sponsors and enablers again resupplying it. Advertisement To that end, it aims to leverage President Donald Trump's hopes to end the bloodshed as well as: Israeli public opinion, include the deep desire to recover the 20 or so still living hostages as well as the remains of the dozens who've died in captivity, plus general war-weariness and partisan opposition to Prime Minister Benjamin Netanyahu and his coalition Sympathy for its other hostages: Gaza's 2 million civilians. Hamas has never cared a whit for their lives or well-being, except as potential recruits, human shields and reason for an influx of aid that the terrorists can siphon off for their use. It will happily martyr any or all of them for the cause of destroying Israel — even as it pretends to make concessions in their name to serve its true agenda. Advertisement Its de facto fifth column all across the West, including the 'tentifada' fanatics and fools on Columbia and other campuses, and all the politicians and media figures who buy the terrorists' propaganda. The dogged self-deception of the international 'peace process' veterans, still imagining that a 'two-state solution' is the key to resolving all the region's conflicts — an 'answer' that's now a complete fantasy that disregards every development of the last three decades. Arab rulers' inability to simply abandon decades of anti-Israel propaganda even though they (mostly) recognize it no longer serves their most urgent needs. Israel's current offensive has already taken out hundreds more Hamas fighters and yet another round of leadership, including the last Sinwar. The IDF is poised to take full control of Gaza, clear the final bunkers and tunnels and crush the remaining terror brigades. Advertisement And Jerusalem has cut off Hamas' resupply, refusing to allow aid to enter Gaza without firm controls that ensure it goes straight to civilians. Not allowing the terrorists to capture it — and to charge civilians for access to any of it — has helped turn the tide of public opinion: Ordinary Gazans increasingly know the war continues only because Hamas won't surrender or even negotiate a departure of its remaining forces. Witkoff's latest offer would have Hamas turn over 10 living hostages and a dozen or two bodies, in exchange for 125 terrorists serving life sentences plus another 1,000-plus jailbirds and a 60-day ceasefire and ongoing talks toward a full peace settlement. But Hamas knows full well that Netanyahu won't end the war until the terrorists are all dead, surrendered or expelled from Gaza: He refuses to allow for any possibility of another Oct. 7, and Israeli public opinion so far supports him. Advertisement So the terror group's counteroffer is to demand some kind of guarantee that Washington won't let the IDF resume operations when the 60 days are up, as well as the resumption of aid entering under UN or similar auspices, without Israeli controls. As things stand, Hamas is toast within months. To get hostages returned, Israel will allow it a respite — and so risk some development (Netanyahu's ouster, a drastic shift in the region, Washington concluding it needs the war ended; who knows?) that would let the terror group hang on in Gaza. Unless Team Trump decides to overrule Israel's unchanged war goals, Hamas will have to settle for that hope of a lifeline, or no deal is happening.
New York Post
34 minutes ago
- New York Post
‘60 Minutes' has history of cozy interviews and self-promotion
Beware of those who publicly declare that their stuff doesn't stink. Recently, CBS newsman and '60 Minutes' regular Scott Pelley made news and noise when he seized the close of the venerable program to deliver an appeal, threat or whatever, depending on how one heard it, to CBS News parent Paramount, as it was reportedly preparing to settle a lawsuit brought last year by President Trump over the show's very cozy interview with VP Kamala Harris during last year's presidential campaign. Pelley cited the week's resignation of '60 Minutes' executive producer, Bill Owens, adding, 'Paramount began to supervise our content in new ways. None of our stories has been blocked, but Bill felt he lost the independence that honest journalism requires. … Bill made sure they were accurate and fair. Advertisement 'He was tough that way, but our parent company Paramount is trying to complete a merger. The Trump administration must approve it.'
The Hill
an hour ago
- The Hill
Puerto Rico is Trump's perfect partner in reshoring
President Trump recently signed an executive order to bring pharmaceutical manufacturing back to the U.S. by streamlining the process for the Food and Drug Administration to approve pharmaceutical manufacturing plants. This is the latest in the Trump administration's agenda to protect national security and create American jobs by promoting the reshoring of critical supply chains that Americans rely on every day. These efforts are coupled with international tariffs to encourage domestic manufacturing. Reshoring pharmaceutical manufacturing is not only dire for American national security, but it could have resounding economic impacts across the country. One U.S. jurisdiction that is ready and in a perfect position to partner in this effort is Puerto Rico, where pharmaceutical manufacturing is already a more than $50 billion industry. With complementary efforts underway in Congress and on the island, the White House should look to Puerto Rico as America's pharmaceutical powerhouse while not trapping the island in its current territory status by hindering a future transition to statehood that would further boost the island's manufacturing ability. As a territory, the island is part of the U.S. customs zone and is not subject to U.S. tariffs, and everything that is made in Puerto Rico is 'Made in the USA.' Yet, that same territory status has limited Puerto Rico's economic development by creating persistent uncertainty, underinvestment and an unequal playing field for economic competition. The territory status is unpopular on the island, and Puerto Rican voters have voted in favor of statehood four consecutive times, most recently last November. Trump and Congress have the opportunity of a generation to leverage the pharmaceutical infrastructure and workforce in Puerto Rico to achieve their agenda while also turbocharging the economy on the island, and they have the perfect ally in Puerto Rico to do it with — the island's Republican Gov. Jenniffer González-Colón. González-Colón is leading an ambitious agenda to reshape the national narrative about the island and its people — and ultimately achieve statehood for Puerto Rico. Aligning with the Trump administration's vision to reshore advanced manufacturing of critical products, she issued an executive order in late March and reached out to top White House officials to offer Puerto Rico's well-established, yet currently underutilized, manufacturing capacity as an economic engine to help grow American prosperity. González-Colón's executive order promotes the relocation of overseas manufacturing of pharmaceuticals and other products to Puerto Rico. Much like Trump's executive order, it eliminates barriers and streamlines the process for businesses to move to the island. This action is complementary to the Medical Manufacturing, Economic Development and Sustainability Act, which was recently reintroduced and incentivizes pharmaceutical manufacturing on the island and throughout economically distressed zones across the United States. The bill is designed to attract business to the island in a way that invests in the people of Puerto Rico. It does this by providing an incentive for medical manufacturing facilities to relocate to economically distressed zones, with an incentive dependent on the number of jobs created to ensure money is flowing back into communities. The incentive itself is based on economic factors and applies to communities throughout the United States — an appropriately wide scope that comports with Trump's strong desire to reshore large amounts of production in a short time frame. By tethering the tax credits to what manufacturers invest directly into wages, salaries and real middle-class benefits, the proposal creates good-paying, quality American jobs. Reshoring to Puerto Rico would mean that critical pharmaceuticals and medical devices, as well as other products that are currently manufactured overseas in China and other nations, would now be produced in America. This would create thousands of well-paying manufacturing jobs that Puerto Rico needs to turbocharge the modest economic progress it's made in recent years. The increased consumer demand on the island would help boost the approximately $70 billion in annual interstate commerce, resulting in more jobs and profits stateside. Puerto Rico is a natural partner in reshoring the medical and pharmaceutical manufacturing industry within U.S. borders. The island's leaders share in the White House's vision of a more prosperous pharmaceutical manufacturing industry and are working to ensure reshoring efforts do not trap Puerto Rico in its current territory status but instead enable it to reach its full potential as an engine of economic growth and prosperity as a future state of our Union. Manufacturing makes America stronger, especially when it lifts up communities and the hard-working American citizens that make 'Made in the USA' a possibility, including those in Puerto Rico.
